FDA Takes Ethics Into Its Own Hands; Foreign Trials Now Subject To Only GCP
Executive Summary
FDA is revising its policy on accepting trials conducted abroad, replacing language concerning protections for human subjects to require that firms follow Good Clinical Practice standards instead of adhering to the Declaration of Helsinki
You may also be interested in...
CME Reforms Under PhRMA Code Increase The Influence Of ACCME
The Pharmaceutical Research and Manufacturers of America's revisions to its code on interactions with health care professionals will strengthen the influence of the Accreditation Council for Continuing Medical Education
CME Reforms Under PhRMA Code Increase The Influence Of ACCME
The Pharmaceutical Research and Manufacturers of America's revisions to its code on interactions with health care professionals will strengthen the influence of the Accreditation Council for Continuing Medical Education
Sponsors Often Compromise Ethics For Cost Efficiency With Trial Outsourcing
As drug sponsors opt to cut costs by outsourcing clinical trials to emerging nations such as India, incomplete patient consent forms are one of several rising ethical concerns linked to such demand